• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Thyroid Disorder Market

    ID: MRFR/Pharma/2031-CR
    118 Pages
    Rahul Gotadki
    July 2019

    Thyroid Disorder Market Research Report Information by Type (Hypothyroidism and Hyperthyroidism), Treatment (Medications, Radioactive Iodine Therapy, and Surgery), Route of Administration (Oral, Intravenous and others), End-User (Hospitals, Clinics, and others) and Region (Americas, Europe, Asia-Pacific, and Middle East & Africa) - Forecast till 2032

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Thyroid Disorder Market Research Report - Forecast till 2032 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Thyroid Disorder Market Summary

    The Global Thyroid Disorder Market is projected to grow from 2.53 USD Billion in 2024 to 3.98 USD Billion by 2035.

    Key Market Trends & Highlights

    Thyroid Disorder Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 4.2 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 3.98 USD Billion, indicating substantial growth opportunities.
    • In 2024, the market is valued at 2.53 USD Billion, reflecting the current demand for thyroid disorder treatments.
    • Growing adoption of advanced diagnostic technologies due to increasing awareness of thyroid disorders is a major market driver.

    Market Size & Forecast

    2024 Market Size 2.53 (USD Billion)
    2035 Market Size 3.98 (USD Billion)
    CAGR (2025-2035) 4.2%

    Major Players

    Pfizer Inc (US), AbbVie Inc (US), Merck KGaA (Germany), Abbott Laboratories (US), GlaxoSmithKline PLC (UK), RLC Labs (US), Mylan NV (US)

    Thyroid Disorder Market Drivers

    Aging Population

    The aging demographic is a crucial factor influencing the Global Thyroid Disorder Market Industry. As individuals age, the risk of developing thyroid disorders escalates, particularly among women. With the global population aged 65 and older projected to reach 1.5 billion by 2050, the demand for thyroid-related healthcare services is expected to surge. This demographic shift necessitates an expansion of treatment options and healthcare resources, thereby propelling market growth. The industry must adapt to meet the needs of this growing population, ensuring that adequate support and therapies are available.

    Market Growth Projections

    The Global Thyroid Disorder Market Industry is poised for substantial growth, with projections indicating a market size of 2.53 USD Billion in 2024 and an anticipated increase to 3.98 USD Billion by 2035. This growth trajectory suggests a compound annual growth rate of 4.2% from 2025 to 2035, reflecting the rising demand for effective treatments and diagnostic solutions. The market dynamics are influenced by various factors, including the increasing prevalence of thyroid disorders, advancements in technology, and growing awareness among the population.

    Growing Awareness and Education

    Increased awareness and education regarding thyroid health are pivotal in shaping the Global Thyroid Disorder Market Industry. Public health campaigns and initiatives aimed at educating individuals about the symptoms and risks associated with thyroid disorders are fostering early diagnosis and treatment. This heightened awareness is likely to lead to an increase in healthcare consultations and screenings, thereby driving market growth. As more individuals recognize the importance of thyroid health, the industry anticipates a compound annual growth rate of 4.2% from 2025 to 2035, reflecting the positive impact of educational efforts.

    Rising Prevalence of Thyroid Disorders

    The increasing incidence of thyroid disorders globally is a primary driver of the Global Thyroid Disorder Market Industry. Conditions such as hypothyroidism and hyperthyroidism are becoming more prevalent, with estimates suggesting that approximately 12 percent of the population will develop a thyroid condition in their lifetime. This growing patient population necessitates enhanced diagnostic and therapeutic solutions, contributing to market growth. In 2024, the market is projected to reach 2.53 USD Billion, reflecting the urgent need for effective management strategies and treatments for thyroid-related ailments.

    Advancements in Diagnostic Technologies

    Technological innovations in diagnostic tools are significantly impacting the Global Thyroid Disorder Market Industry. Enhanced imaging techniques, such as high-resolution ultrasound and advanced blood tests, facilitate early detection and accurate diagnosis of thyroid disorders. These advancements not only improve patient outcomes but also drive market demand for sophisticated diagnostic equipment. As healthcare providers increasingly adopt these technologies, the market is expected to expand, with projections indicating a growth to 3.98 USD Billion by 2035. This trend underscores the importance of continuous investment in research and development within the industry.

    Regulatory Support and Policy Initiatives

    Supportive regulatory frameworks and policy initiatives are fostering growth in the Global Thyroid Disorder Market Industry. Governments and health organizations are increasingly recognizing the importance of thyroid health, leading to the implementation of guidelines and funding for research. These initiatives aim to improve access to care and promote the development of new treatments. As regulatory bodies prioritize thyroid health, the market is likely to benefit from increased investment and innovation, further driving growth in the coming years.

    Key Companies in the Thyroid Disorder Market market include

    Industry Developments

    Recent development in the thyroid disorder market are

    • In November 2015, a program that focuses on managing the daily routine of those having the life-long condition of hypothyroidism was launched by Abbie under Good Morning Hypothyroidism (GMH).

    • In October 2016, ThyroTest was introduced by Abbott acquired Alere Inc., a service provider organization and a diagnostic device manufacturer introduced in the market, which is a test to detect hypothyroidism.

    • In March 2018, an orally available tyrosine kinase inhibitor was discovered by Eisai.

    • Also, in the same month, it was announced by Eisai Co Ltd and Merck about their strategic collar radiation. They are popularly called MSD after the collaboration.

    • The commercialization of LENVIMA was also done in the year 2018.

    Future Outlook

    Thyroid Disorder Market Future Outlook

    The Global Thyroid Disorder Market is projected to grow at a 4.2% CAGR from 2024 to 2035, driven by increasing prevalence, advancements in diagnostics, and rising awareness.

    New opportunities lie in:

    • Develop innovative digital health solutions for remote monitoring and management.
    • Expand product lines to include personalized medicine tailored to genetic profiles.
    • Invest in educational campaigns to raise awareness about thyroid health and treatment options.

    By 2035, the market is expected to demonstrate robust growth, reflecting enhanced treatment options and increased patient engagement.

    Market Segmentation

    Thyroid Disorder Type Outlook

    Thyroid Disorder End-User Outlook

    Thyroid Disorder Regional Outlook

    • Pfizer Inc (US)
    • AbbVie Inc (US)
    • Merck KGaA (Germany)
    • Abbott Laboratories (US)
    • GlaxoSmithKline PLC (UK)
    • RLC Labs (US)
    • Mylan NV (US)

    Thyroid Disorder Treatment Outlook

    Thyroid Disorder Route of Administration Outlook

    Report Scope

    Report Attribute/Metric Details
    Market Size 2023 2.41 (USD Billion)
    Market Size 2024 2.53 (USD Billion)
    Market Size 2032 3.55 (USD Billion)
    Compound Annual Growth Rate (CAGR) 3.87 % (2024 - 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2023
    Market Forecast Period 2024 - 2032
    Historical Data 2019 - 2023
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Pfizer Inc (US), AbbVie Inc (US), Merck KGaA (Germany), Abbott Laboratories (US), GlaxoSmithKline PLC (UK), RLC Labs (US), and Mylan NV (US)
      Key Market Opportunities ·       Rising prevalence of thyroid disorders globally ·       Increased awareness and education about thyroid health ·       Advancements in diagnostic technologies
      Key Market Drivers ·       Advances in treatment options ·       Growing healthcare expenditure ·       Favourable government policies and reimbursement schemes

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    What will be the possible market valuation of the thyroid disorder market?

    The global thyroid disorder market is predicted to touch USD 3.55 Billion by 2032.

    At what CAGR is the thyroid disorder market expected to grow over the forecast period?

    The thyroid disorder market is predicted to grow at a 3.87% CAGR between 2024-2032.

    Which region is predicted to lead the thyroid disorder market?

    The Americas is predicted to lead the thyroid disorder market during the forecast period.

    Who are the key competitors in the thyroid disorder market?

    Key competitors in the thyroid disorder market include Mylan, GlaxoSmithKline Plc, Abbott Laboratories, RLC Labs, Merck KGaA, AbbVie Inc., Pfizer Inc, and Allergan Inc.

    Name the end-user subtype that dominates the thyroid disorder market?

    It is most likely that hospitals will dominate the market.

    Thyroid Disorder Market Research Report - Forecast till 2032 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials